Hyperuricemia as a predictor of non-alcoholic fatty liver disease
https://doi.org/10.21886/2712-8156-2022-3-2-19-24
Abstract
Non-alcoholic fatty liver disease (NAFLD) is currently a widespread disease among the adult population and, being a component of the metabolic syndrome (MS), is often associated with obesity, insulin resistance (IR), type 2 diabetes mellitus (DM2), cardiovascular diseases (CVD). Many authors in scientific studies have found that hyperuricemia (HU) can be considered as a predictor of non-alcoholic fatty liver disease (NAFLD), as well as other diseases associated with metabolic syndrome (MS).
About the Authors
M. E. StatsenkoRussian Federation
Statsenko Mikhail Evgenievich, Dr. Sci. (Med.), prof, professor of internal diseases department
Volgograd
S. V. Turkina
Russian Federation
Turkina Svetlana Vladimirovna, Dr. Sci. (Med.), professor of internal diseases department
Volgograd
M. N. Ustinova
Russian Federation
Ustinova Margarita Nikolaevna, Cand. Sci. (Med.), associate professor of internal diseases department
Volgograd
A. V. Tumarenko
Russian Federation
Tumarenko Alexandr Vladimirovich, Cand. Sci. (Med.), associate professor of internal diseases department
Volgograd
O. Yu. Sviridenko
Russian Federation
Sviridenko Oleg Yuryevich, Cand. Sci. (Med.), associate professor of internal diseases department
Volgograd
A. O. Sviridenko
Russian Federation
Sviridenko Anton Olegovich, assistant of professor of internal diseases department
Volgograd
References
1.
Review
For citations:
Statsenko M.E., Turkina S.V., Ustinova M.N., Tumarenko A.V., Sviridenko O.Yu., Sviridenko A.O. Hyperuricemia as a predictor of non-alcoholic fatty liver disease. South Russian Journal of Therapeutic Practice. 2022;3(2):19-24. (In Russ.) https://doi.org/10.21886/2712-8156-2022-3-2-19-24